Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2008
Business Overview: The Company manufactures and markets herbal products, vitamin and mineral supplements, and personal care items through a direct sales force of independent Distributors and Managers. Operations are divided into three segments: Nature's Sunshine Products (United States), Nature's Sunshine Products (International), and Synergy Worldwide.
Key Financial Metrics
Amounts in thousands, except per-share data.
| Metric | Three Months Ended June 30, 2008 | Six Months Ended June 30, 2008 |
|---|---|---|
| Net Sales Revenue | $97,879 | $196,436 |
| Operating Income | $3,378 | $4,277 |
| Net Loss | $(701) | $(1,144) |
| Diluted Net Loss Per Share | $(0.05) | $(0.07) |
| Cash and Cash Equivalents | $46,181 (Balance Sheet) | $46,181 (Balance Sheet) |
| Net Cash Provided by Operating Activities | N/A | $7,054 |
| Working Capital | $27,337 (Calculated) | N/A |
| Total Debt | $0 (No long-term debt reported) | $0 |
Margins (Six Months 2008):
- Gross Margin (Net Sales less COGS): 81.7%
- Operating Margin: 2.2%
- Effective Tax Rate: 127% (Driven by discrete items and valuation allowances)
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 8.1% for the quarter and 6.6% for the six-month period compared to 2007. This was driven primarily by a 24.5% increase in International sales (particularly in Russia, Ukraine, and Europe).
- Segment Performance: While the International segment grew, the Synergy Worldwide segment declined 18.8% for the six months due to the loss of key distributor networks in the U.S. and Japan. U.S. sales remained relatively flat with a 1.8% increase.
- Profitability: Operating income decreased 31.3% for the six-month period ($4.3M vs $6.2M) due to increased Selling, General, and Administrative (SG&A) expenses. SG&A rose 11.1% to support international expansion and new market entry.
- Net Loss Improvement: Despite lower operating income, the Net Loss improved significantly (decreased by 73.8% for the six months) due to a lower provision for income taxes compared to the prior year.
- Liquidity: Cash and cash equivalents increased slightly to $46.2 million. Working capital decreased from $32.0 million to $27.3 million.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary & Outlook: Management expects working capital requirements to be met through existing cash and operating cash flows. However, they noted that a prolonged economic downturn or decrease in product demand could adversely affect long-term liquidity. No specific numerical guidance for future periods was provided in this filing.
Unusual Items & Contingencies:
- Income Taxes: The effective tax rate (127% for six months) significantly exceeds the statutory rate due to increases in tax liabilities for uncertain tax positions and foreign valuation allowances. A benefit for unremitted foreign earnings in 2008 reduced the rate compared to 2007.
- Restricted Investments: The Company holds $2.05 million in Auction Rate Securities (ARS) that experienced failed auctions in Q1 2008. These are classified as restricted investments and are currently illiquid, though management believes they will be liquidated near carrying value.
- Legal Proceedings:
- Class Action: A shareholder class action lawsuit regarding alleged misrepresentations is in the discovery phase, with trial scheduled for April 2010. The Company is vigorously defending the claims.
- SEC/DOJ Investigations: The Company is cooperating with ongoing investigations by the SEC and DOJ regarding prior financial restatements.
- SEC Section 12(j): An administrative proceeding to revoke the registration of the Company's common stock is pending review by the SEC, with oral arguments rescheduled for January 2009.
Internal Controls: The Company reported that disclosure controls and procedures were not effective as of June 30, 2008, due to six material weaknesses in internal control over financial reporting (including risk assessment, GAAP application, and IT controls). Remediation efforts are ongoing.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of remediation for the six material weaknesses in internal controls, specifically regarding financial reporting processes and IT access controls.
- Legal Exposure: Monitor the status of the SEC Section 12(j) proceeding and the shareholder class action lawsuit, as unfavorable outcomes could materially impact operations or stock trading.
- Liquidity of ARS: Track the liquidity status of the $2.05 million in Auction Rate Securities and any potential write-downs if they cannot be redeemed at par.
- Tax Contingencies: Review the $16.4 million accrued liability for unrecognized tax positions and the potential for future adjustments.
- Segment Trends: Assess the sustainability of International sales growth versus the continued decline in the Synergy Worldwide segment.